Where Do the Democratic Candidates Stand on Health Reform and Prescription Drug Prices?
This quick primer explains where the 7 Democratic candidates for president participating in the Feb. 25 debate in South Carolina stand on health reform.
View the Latest: Prescription Drugs
Filter
-
-
Questions about Prescription Drug Importation? KFF Has Answers
News ReleaseWith lowering prescription drug costs a top priority for Americans, the Trump Administration, presidential candidates, members of Congress, and several states are proposing to allow the importation of drugs from abroad, chiefly Canada.
-
Visualizing Health Policy: US Statistics on Surprise Medical Billing
Other PostThis infographic examines public opinion on surprise medical billing in the United States as part of the Visualizing Health Policy infographic series, produced in partnership with the Journal of the American Medical Association (JAMA).
-
Visualizing Health Policy: US Statistics on Surprise Medical Billing
News ReleaseThis Visualizing Health Policy infographic looks at the experience of unexpected or “surprise” medical bills in the United States. Out-of-network charges typically expose individuals to higher cost-sharing when they use services, and may lead to balance billing – in which providers bill patients directly, and often unexpectedly, at a higher rate.
-
Health Issues and the Election Quiz
FeatureTest your knowledge about health facts, policy issues and proposals that are emerging among the 2020 presidential candidates. The 10 questions focus on health issues in the 2020 election, including: health care costs, prescription drug prices, the Affordable Care Act and changes in health insurance coverage, reproductive health, and Medicare-for-all and public option proposals.
-
Drug Overdose Deaths Have Declined Nationally and in Most States, Though Some States Have Seen Increases
FeatureWhile drug overdose deaths have declined nationally and in most states, 19 states have seen increases since 2017.
-
JAMA Forum: Don’t Be Surprised if the Next Big Health Care Debate Is About Drug Prices
PerspectiveIn this post for The JAMA Forum, Larry Levitt examines both the Democratic candidates' proposals and the Trump administration's record on lowering drug prices, which remains a top issue for the public with bi-partisan support.
-
KFF Health Tracking Poll – January 2020: Medicare-for-all, Public Option, Health Care Legislation And Court Actions
FeatureThis month's KFF Health Tracking poll examines public opinion and knowledge of Medicare-for-all and a public option, President Trump's approval on health care programs and issues, the public's priorities for Congress, and public opinion on the Affordable Care Act and the Texas v. U.S. court case.
-
Pricing and Payment for Medicaid Prescription Drugs
Issue BriefAttention to high list prices continues at both the state and federal levels with a number of policy proposals aimed at lowering drug prices and there is renewed interest in drug prices and reimbursement within Medicaid. Changes made in 2016 to federal rules governing how state Medicaid programs pay for drugs aimed to make the prices paid more accurate, but increased reliance on pharmacy benefit managers (PBMs) pose challenges to drug price transparency. This brief explains Medicaid prescription drug prices to help policymakers and others understand Medicaid’s role in drug pricing and any potential consequences of policy changes for the program.
-
Among the Most Commonly Used Antiretrovirals Covered by Part D in 2017, 9 of 10 Had List Prices Exceeding Inflation
Feature9 of 10 Most Commonly Used ARVs in Part D Had List Prices Above Inflation Download…